UPDATE: Valeant Pharma (VRX) Exploring Sale of Eye-Surgery Equipment Business - DJ

(Updated - November 2, 2016 2:50 PM EDT)

Valeant Pharma (NYSE: VRX) is exploring a sale of its eye-surgery equipment business, according to Dow Jones, citing source.

The unit could fetch $2.5 billion, the report said, though discussions are still preliminary.

You May Also Be Interested In

• BHP Group (BHP) Said to Weigh Potential Takeover of Anglo American (NGLOY) - Bloomberg
• Boeing (BA) Talks For Spirit (SPR) Purchase Only Progressing Slowly - Bloomberg
• Hibbett Sports (HIBB) Acquired by JD Sports Fashion for $87.50/sh or $1.1B